Millennium Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Millennium Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-40,100	Closed	-$2.14M	–	3986
2016 Q1	$2.14M	Sell	40,100 -110,437	-73%	-$8.15M	0.01%	1735
2015 Q4	$17M	Sell	150,537 -1,035,070	-87%	-$114M	0.04%	640
2015 Q3	$140M	Buy	1,185,607 +448,645	+61%	+$58.6M	0.27%	53
2015 Q2	$57.1M	Sell	736,962 -312,827	-30%	-$20.5M	0.11%	227
2015 Q1	$60.7M	Buy	1,049,789 +96,407	+10%	+$4.09M	0.11%	201
2014 Q4	$30.7M	Buy	953,382 +428,258	+82%	+$12.9M	0.07%	413
2014 Q3	$12.8M	Buy	525,124 +136,611	+35%	+$2.78M	0.03%	731
2014 Q2	$6.89M	Sell	388,513 -38,984	-9%	-$628K	0.02%	1013
2014 Q1	$8.55M	Buy	427,497 +91,943	+27%	+$1.78M	0.02%	898
2013 Q4	$5.63M	Buy	+335,554	New	+$4.64M	0.02%	1072
2013 Q3	–	Sell	-61,217	Closed	-$342K	–	3873
2013 Q2	$342K	Buy	+61,217	New	+$371K	﹤0.01%	2525

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Millennium Management's ANAC Position: Q2 2016 in Review

Millennium Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 40,100 shares — an estimated $2.14M sold.

Millennium Management first reported a position in ANAC in Q2 2013 and held it in 11 quarters. The position peaked at $140M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Millennium Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Millennium Management sold 40,100 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.14M.
Millennium Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 11 quarters.
Millennium Management's ANACOR PHARMACEUTICALS INC COM position peaked at $140M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Millennium Management's 13F filing for Q2 2016, filed 15 Aug 2016.